Rx Imports Will Resolve Shortage Of Injectable Nutrition Drugs After Congressional Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Fresenius Kabi USA’s Norway plant is to supply the US with three injectable drugs used in total parenteral nutrition, primarily for treatment of premature infants; FDA has previously permitted importation of 11 other drugs that have been subject to shortages.